Cargando…
IAC方案治疗复发/难治急性髓系白血病疗效与安全性分析：前瞻性随机对照研究
OBJECTIVE: To evaluate the efficacy and toxicity profiles of idarubicin, cytarabine, and cyclophosphamide (IAC) in relapse/refractory acute myeloid leukemia (AML). METHODS: This study was a prospective, randomized controlled clinical trial with the registration number NCT02937662. The patients were...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189487/ https://www.ncbi.nlm.nih.gov/pubmed/35680626 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.04.004 |